Eylea® hd (aflibercept) injection 8 mg pivotal data in wet age-related macular degeneration (wamd) and diabetic macular edema (dme) published in the lancet

Published results show eylea hd with extended 12- or 16-week dosing regimens demonstrated non-inferior vision gains to standard of care eylea ® (aflibercept) injection 2 mg with fixed 8-week dosing in patients with wamd and dme in the first year

REGN Ratings Summary

REGN Quant Ranking